fda glp-1 warning october 2025 The has received hundreds of adverse event reports tied to compounded GLP-1s. PRI's brief warns that patients should know the risks before trusting knockoff versions. Read the brief: https://medecon.org/unauthorized-glp-1-knockoffs GLP-1s in 2026: What Brokers

A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfort

Rachele Pojedic, Chief Science Officer at Restore

This fascinating development comes from a study led by Dr

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Stop struggling with food noise and start seeing the results you deserve

This guide covers evidence-based recommendations for coffee consumption during semaglutide therapy, including timing strategies, preparation methods, and signs that temporary caffeine reduction may benefit your treatment experience